
Quantitative 68Ga-PSMA-11 PET and Outcomes in Metastatic Castration-resistant Prostate Cancer following 177Lu-PSMA-617
22/10/2024
0:00
30:54
Dr. Ashwin Singh Parihar speaks with Dr. Phillip Kuo, Dr. Andrew Armstrong, and Dr. Ken Herrmann about how 68Ga-PSMA-11 PET can predict response of metastatic prostate cancer following 177Lu-PSMA-617 therapy. The VISION Trial.
Mais episódios de "Radiology Podcast | RSNA"



Não percas um episódio de “Radiology Podcast | RSNA” e subscrevê-lo na aplicação GetPodcast.







